We are deeply saddened by this tragedy and want to express our condolences to the family of the deceased and those affected by this tragedy. We are working closely with Sellen Construction, Edmonds Police Department, Snohomish County Fire District 1, and Labor & Industries to investigate the accident and determine what happened.
Although the accident resulted in temporary disruption of power at some of the outlying buildings on the Swedish Edmonds campus, no care services at the main hospital were impacted aside from a temporary safety pause for cardiac cath lab and some elective procedure patients. Power was completely restored to the campus by 3:45 pm.
Out of respect for the family of the victim, those affected by the accident and the ongoing investigation, Swedish cannot provide additional comment at this time.
Swedish Health Services CEO Tony Armada was interviewed Furst Group as part of Modern Healthcare’s Top 25 Minority Executives in Healthcare. In his interview, Armada discusses his family’s connection to health care, achieving excellence in care and what convinced him that taking the helm at Swedish is the right opportunity for him to pursue.
Read the full interview on Furstgroup.com.
Pacific Cancer Research Consortium Receives $6.6 Million Grant to Expand Access to Oncology Care, Trials
Consortium includes Swedish Cancer Institute, Providence Portland Medical Center and St. Luke’s Mountain States Tumor Institute
FOR IMMEDIATE RELEASE
Contacts: Clay Holtzman, Swedish Cancer Institute, 206-386-2748, firstname.lastname@example.org
Jean Marks, Providence Portland Medical Center, 503-215-6433, email@example.com
Ken Dey, St. Luke’s Mountain State Tumor Institute, 208-381-2894, firstname.lastname@example.org
SEATTLE — August 5, 2014 — The National Cancer Institute’s Community Oncology Research Program (NCORP) has awarded a consortium of community cancer centers from the Western United States a five-year grant worth $6.6 million to improve access to lifesaving cancer care and clinical trials across a five-state region.
The Pacific Cancer Research Consortium is led by three primary sites: the Swedish Cancer Institute (SCI) in Seattle, which will serve as the grant’s fiduciary, Providence Portland Medical Center (PPMC) in Oregon and St. Luke’s Mountain States Tumor Institute (MSTI) in Boise, Idaho. The consortium also includes 37 other clinical care sites in Alaska, California, Idaho, Oregon and Washington. The program opened on Aug. 4.
The Consortium’s grant is part of a $93 million funding cycle announced today by NCORP and awarded to 53 researchers across the country.
“We are extremely honored that the National Cancer Institute Community Oncology Research Program has selected our consortium to lead the expansion of cancer clinical trials throughout the Western region,” said Thomas Brown, M.D., executive director of the Swedish Cancer Institute. “Together Swedish Cancer Institute, Providence Cancer Center at Providence Portland Medical Center, St. Luke’s Mountain States Tumor Institute, and a network of clinical care sites are giving patients and their families access to the most current investigational therapies that give hope to advancing the care of cancer patients throughout our region and beyond. Access to clinical trials is the key to providing high quality cancer care in the 21st century.”
Swedish Cancer Institute’s Henry Kaplan, M.D., co-published and helped fund new study
Contact: RSNA Media Relations: 1-630-590-7762
Swedish Cancer Institute, Clay Holtzman, (206) 386-2748, email@example.com
OAK BROOK, Ill. – Mammography-detected breast cancer is associated with a shift to earlier stage diagnosis in older women, subsequently reducing the rate of more advanced, difficult-to-treat cases, according to a new study published online in the journal Radiology. Researchers said the findings lend support to regular mammography screening in women ages 75 and older.
The value of mammography screening in older women has been subject to much debate in recent years. The American Cancer Society recommends annual mammograms for women age 75 and older as long as they are in good health, while the U.S. Preventive Services Task Force (USPSTF) does not recommend mammography screening in this age group, citing insufficient evidence to evaluate benefits and harms.
A lack of research is chiefly responsible for the divergent recommendations, according to Judith A. Malmgren, Ph.D., affiliate assistant professor at the University of Washington’s School of Public Health and Community Medicine in Seattle.
“There are no studies on women age 75 and older, despite the fact that they are at the highest risk for breast cancer,” she said.
Dr. Malmgren and her research partner, Henry Kaplan, M.D., from the Swedish Cancer Institute in Seattle, recently looked at the impact of mammography detection on older women by studying data from an institutional registry that includes more than 14,000 breast cancer cases with 1,600 patients over age 75.
SUNNYVALE, Calif. — July 24, 2014 — Intuitive Surgical (NASDAQ: ISRG) today announced the launch of the first annual Intuitive Surgical Robotics Fellowship Course through the American Association for Thoracic Surgery’s (AATS) Graham Foundation. The course, which began in late July, is designed to offer an introductory training course in robotics to eight North American general thoracic surgery fellows and their attending surgeons. General thoracic surgeons specialize in procedures performed in the chest, such as surgery for lung cancer.
Among the first annual class members is Swedish Surgeon and Thoracic Surgery Fellow Lisa Brown, M.D.
The eight fellows will have the opportunity to spend two days at Intuitive Surgical's Atlanta facility to receive advanced training on Intuitive Surgical's da Vinci® Surgical System. Course Director Robert Cerfolio, MD, leading robotic surgery expert and Chief of the Section of Thoracic Surgery at the University of Alabama, will provide clinical instruction. This year’s fellowship recipients come from Duke University, East Carolina University, Mayo Clinic, New York University, Swedish Medical Center, University of Kentucky, University of Southern California and University of Toronto.
"This is about training young surgeons in innovative new technologies and providing surgeons-in-training the opportunity to learn about the latest surgical technologies and techniques," said Ray Pasciuto, Director of Development for AATS’s Graham Foundation. "We are grateful for Intuitive Surgical’s commitment to product training and its support of our fellowship course."
"We welcome the opportunity to support surgeons early in their professional development as they experience advanced technologies that enable the delivery of more minimally invasive thoracic surgery," said Myriam Curet, Senior Vice President, Chief Medical Officer at Intuitive Surgical.
Swedish Launches Studies Examining Focused Ultrasound as a Potential Treatment for Parkinson’s disease, Brain Tumors
Swedish Neuroscience Institute leads national ultrasound technology research
FOR IMMEDIATE RELEASE
Contact: Clay Holtzman, Swedish, (206) 998-5028, firstname.lastname@example.orgSEATTLE — July 30, 2014 — The Swedish Neuroscience Institute (SNI) is expanding its study of focused ultrasound as a novel treatment for brain disorders with the opening of two clinical trials examining the treatment of Parkinson’s disease and brain tumors. The new trials add to the institute’s ongoing study of focused ultrasound for a treatment of essential tremor (ET).
“SNI is one of the few locations in the world where focused ultrasound is being studied at this level. These efforts exemplify SNI’s ongoing mission to deliver leading edge treatment for brain and spinal conditions,” said David Newell, M.D., Chief of Neurosciences at SNI. “We are honored to be a pioneer in this field and are eager to produce translational results.”
These trials come after SNI launched a study last year examining focused ultrasound’s potential as a treatment for essential tremor, a common neurological disorder resulting in involuntary shaking. The original study was designed to determine viability and safety of ultrasound treatment in improving the quality of life for those affected. Together, these three studies place SNI at the forefront of clinical care providers studying focused ultrasound as a treatment approach.
Anthony Armada, FACHE, CEO of Swedish Health Services, was recently named one of ‘500+ People to know in Healthcare’ by Becker’s Hospital Review. The list says this about Armada:
“Anthony Armada is CEO of Swedish Health Services in Seattle. Mr. Armada was named to lead the five-hospital system in October, prior to which he served as president of Advocate Lutheran General Hospital in Park Ridge, Ill.”
More information about the Swedish newsroom
Explore the rest of the Swedish blog
Swedish has a social media policy
See who is blogging at Swedish
Check out more from Swedish:
See who else is blogging at Swedish